8-KThe WireRoutine
Shareholder Vote
Filed Jun 30, 2021 · 5y ago · Accession 0001564590-21-035335
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K
- Filing date
- Jun 30, 2021
- Report date
- Jun 29, 2021
- Document
- imra-8k_20210701.htm
- Size
- 43 KB